This is a retrospective, researcher-initiated, database-based study that will retrospectively observe the treatment and medication patterns of about 22,500 patients with heart failure from 25 heart failure centers and 25 non-heart failure centers in the database of heart failure center. The proportion of patients with heart failure treatment drugs reaching the target dose recommended in the guidelines and discontinuation rate will be observed at 1 month, 3 months and 12 months follow up time point. The purpose of this study is to illustrate the current HF treatment status in HF center hospitals and non-HF center hospitals, which may provide insights for improving the clinical practice of heart failure treatment in China, and promote the standardization of heart failure treatment in China.
Study Type
OBSERVATIONAL
Enrollment
22,500
no intervention
Department of Cardiology, Peking University First Hospital
Beijing, China
Number of GDMT drugs (classified as RAASi (including ARNI), beta blockers, MRA and SGLT2i)
Numbers of GDMT drugs of HF patients stratified by HF ejection fraction and by HF Center and Non-HF Center
Time frame: At baseline and at 1 month, 3 month, 12 month follow-up time point
Use rates of GDMT drugs
The percentage of patients using each GDMT drug，stratified by HF ejection fraction and by HF Center and Non-HF Center
Time frame: At baseline and at 1 month, 3 month, 12 month follow-up time point
The proportion of patients using 2 types of GDMT drugs
The percentage of patients using 2 of any 4 GDMT drugs，stratified by HF ejection fraction and by HF Center and Non-HF Center
Time frame: At baseline and at 1 month, 3 month, 12 month follow-up time point
The proportion of patients using 3 types of GDMT drugs
The percentage of patients using 3 of any 4 GDMT drugs，stratified by HF ejection fraction and by HF Center and Non-HF Center
Time frame: At baseline and at 1 month, 3 month, 12 month follow-up time point
The proportion of patients using 4 types of GDMT drugs
The percentage of patients using all types of GDMT drugs，stratified by HF ejection fraction and by HF Center and Non-HF Center
Time frame: At baseline and at 1 month, 3 month, 12 month follow-up time point
The proportion of patients with each GDMT drug in the target dose
The percentage of patients who achieved the target dose of each GDMT drug, stratified by HF ejection fraction and by HF Center and Non-HF Center
Time frame: at 1 month, 3 month, 12 month follow-up time point
Discontinuation rate of each GDMT drug
The percentage of patients who discontinued GDMT drugs, stratified by HF ejection fraction and by HF Center and Non-HF Center
Time frame: at 1 month, 3 month, 12 month follow-up time point
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.